1. Home
  2. NVNI vs DTIL Comparison

NVNI vs DTIL Comparison

Compare NVNI & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVNI
  • DTIL
  • Stock Information
  • Founded
  • NVNI 2019
  • DTIL 2006
  • Country
  • NVNI Brazil
  • DTIL United States
  • Employees
  • NVNI N/A
  • DTIL N/A
  • Industry
  • NVNI
  • DTIL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVNI
  • DTIL Health Care
  • Exchange
  • NVNI Nasdaq
  • DTIL Nasdaq
  • Market Cap
  • NVNI 42.9M
  • DTIL 44.1M
  • IPO Year
  • NVNI N/A
  • DTIL 2019
  • Fundamental
  • Price
  • NVNI $0.64
  • DTIL $4.30
  • Analyst Decision
  • NVNI
  • DTIL Strong Buy
  • Analyst Count
  • NVNI 0
  • DTIL 2
  • Target Price
  • NVNI N/A
  • DTIL $39.50
  • AVG Volume (30 Days)
  • NVNI 643.6K
  • DTIL 113.1K
  • Earning Date
  • NVNI 12-31-2024
  • DTIL 11-04-2024
  • Dividend Yield
  • NVNI N/A
  • DTIL N/A
  • EPS Growth
  • NVNI N/A
  • DTIL N/A
  • EPS
  • NVNI N/A
  • DTIL 1.45
  • Revenue
  • NVNI $23,558,620.00
  • DTIL $75,096,000.00
  • Revenue This Year
  • NVNI $25.91
  • DTIL $50.33
  • Revenue Next Year
  • NVNI $17.52
  • DTIL N/A
  • P/E Ratio
  • NVNI N/A
  • DTIL $2.37
  • Revenue Growth
  • NVNI 38.59
  • DTIL 43.62
  • 52 Week Low
  • NVNI $0.33
  • DTIL $4.13
  • 52 Week High
  • NVNI $3.20
  • DTIL $19.43
  • Technical
  • Relative Strength Index (RSI)
  • NVNI 46.09
  • DTIL 24.26
  • Support Level
  • NVNI $0.33
  • DTIL $5.12
  • Resistance Level
  • NVNI $0.66
  • DTIL $6.18
  • Average True Range (ATR)
  • NVNI 0.16
  • DTIL 0.46
  • MACD
  • NVNI -0.02
  • DTIL -0.13
  • Stochastic Oscillator
  • NVNI 26.40
  • DTIL 5.21

About NVNI Nvni Group Limited

Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

Share on Social Networks: